课题基金 / 基金详情

VITAMIN E IN TREATMENT OF IGA NEPHROPATHY IN CHILDREN

VITAMIN E IN TREATMENT OF IGA NEPHROPATHY IN CHILDREN
维生素 E 治疗儿童 IGA 肾病
批准号:
6297046
负责人:
JOSEPH T FLYNN
金额:
$0.02万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

JOSEPH T FLYNN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
IgA nephropathy is a disease of the kidneys which leads to loss of blood and protein in the urine and can lead to severe kidney failure even when it begins in childhood. Unfortunately, there is no proven treatment for IgA nephropathy, although numerous medications have been tried. Vitamin E is a naturally occurring substance that has "anti-oxidant" effects, meaning that it can protect against damage caused by certain oxygen-containing substances called "free radicals. Based upon studies in rats with experimental IgA Nephropathy, some researchers feel that giving Vitamin E to children with IgA Nephropathy may reduce or prevent the development of kidney scarring and therefore reduce the chances of developing kidney failure. This is a multicenter study in which children and young adults with biopsy-proven, clinically mild IgA Nephropathy will be randomized to receive either Vitamin E or placebo once daily for two years. Subjects in the study will be followed for changes in kidney function, hematuria (blood in the urine), and proteinuria to learn whether Vitamin E is an effective treatment for IgA Nephropathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION
VITAMIN E IN TREATMENT OF IGA NEPHROPATHY IN CHILDREN
NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION
PREDNISONE & FISH OIL SUPPLEMENTS IN CHILDREN & YOUNG ADULTS W/ IGA NEPHROLOGY
海外基金